John J. Greisch is corporate vice president and president of Baxter's international operations. In this role, he oversees all international, global manufacturing and supply chain operations. Greisch joined Baxter in 2002 as vice president of finance for Baxter's Renal business. He then assumed the role of vice president of finance and strategy for Baxter's BioScience business before being named president of that business. In 2004, he was named corporate vice president and chief financial officer. Prior to joining Baxter, Greisch was president and CEO of FleetPride Corporation. He also served in a variety of roles, including chief financial officer, treasurer and president at The Interlake Corporation. He was also president of Interlake's European operations based in London. Greisch is a member of the board of directors of TomoTherapy Incorporated, which develops, markets and sells an advanced radiation therapy system for the treatment of a wide variety of cancers. He is also a director of the Children's Memorial Hospital Foundation Board, a trustee with the John G. Shedd Aquarium and serves on the Business School Advisory Board for Miami University's Richard T. Farmer School of Business. Greisch received a bachelor's degree in business administration from Miami University at Ohio and a master's degree in management from Northwestern University's Kellogg Graduate School of Management. He is a Certified Public Accountant and began his business career with PriceWaterhouseCoopers.
